MRI outcomes in early MS

Epub: Kirov et al. Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS. Neurology. 2012.

OBJECTIVE: To characterize and follow the diffuse gray and white matter (GM/WM) metabolic abnormalities in early relapsing-remitting multiple sclerosis using proton magnetic resonance spectroscopic imaging ((1)H-MRSI).

METHODS: Eighteen recently diagnosed, mildly disabled patients (mean baseline time from diagnosis 32 months, mean Expanded Disability Status Scale [EDSS] score 1.3), all on immunomodulatory medication, were scanned semiannually for 3 years with T1-weighted and T2-weighted MRI and 3D (1)H-MRSI at 3 T. Ten sex- and age-matched controls were followed annually. Global absolute concentrations of N-acetylaspartate (NAA), choline (Cho), creatine (Cr), and myo-inositol (mI) were obtained for all GM and WM in the 360 cm(3) (1)H-MRSI volume of interest.

RESULTS: Patients’ average WM Cr, Cho, and mI concentrations (over all time points), 5.3 ± 0.4, 1.6 ± 0.1, and 5.1 ± 0.7 mM, were 8%, 12%, and 11% higher than controls’ (p ≤ 0.01), while their WM NAA (measure of axon content), 7.4 ± 0.7 mM, was 6% lower (p = 0.07). There were increases with time of patients’ WM Cr: 0.1 mM/year, Cho: 0.02 mM/year, and NAA: 0.1 mM/year (all p < 0.05). None of the patients’ metabolic concentrations correlated with their EDSS score, relapse rate, GM/WM/CSF fractions, or lesion volume.

CONCLUSIONS: Diffuse WM glial abnormalities were larger in magnitude than the axonal abnormalities and increased over time independently of conventional clinical or imaging metrics and despite immunomodulatory treatment. In contrast, the axonal abnormalities showed partial recovery, suggesting that patients’ lower WM, NAA levels represented a dysfunction, which may abate with treatment. Absence of detectable diffuse changes in GM suggests that injury there is minimal, focal, or heterogeneous between cortex and deep GM nuclei.

This study demonstrates that conventional MRI is not that definitive, for many years NAA which is concentrated in nerves, was and still is thought of a measure of nerve content. However as can be seen the levels can increase and so it is not an absolute measure of nerve content. They could not detect so many changes in grey matter, but we know that MRI struggled for years to show grey matter lesions. It is not yet a microscope and until it has power it will continue to miss stuff. It is also showing changes that have not been clearly related to any pathology yet.

About the author


Add comment

By MouseDoctor



Recent Posts

Recent Comments